Sprott’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$690K Buy
2,606
+869
+50% +$229K 0.02% 164
2026
Q2
$441K Buy
+1,737
New +$405K 0.01% 188
2016
Q4
– Sell
-7,400
Closed -$874K – 184
2016
Q3
$874K Buy
+7,400
New +$898K 0.03% 140
2014
Q2
– Sell
-127,500
Closed -$12.5M – 132
2014
Q1
$12.5M Sell
127,500
-4,600
-3% -$426K 1.09% 28
2013
Q4
$12.1M Buy
+132,100
New +$12.2M 0.88% 25
2013
Q3
– Sell
-58,100
Closed -$4.99M – 144
2013
Q2
$4.99M Buy
+58,100
New +$4.93M 0.71% 33

Other funds holding JNJ

Sprott's JNJ Position: Q3 2026 in Review

Sprott increased its Johnson & Johnson (JNJ) stake by 50% in Q3 2026, buying an estimated $229K and bringing the position to 2,606 shares worth $690K. The position accounts for 0.02% of the portfolio, ranked #164.

Sprott first reported a position in JNJ in Q2 2013 and has held it in 6 quarters since. The position peaked at $12.5M in Q1 2014. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Sprott held 2,606 shares of Johnson & Johnson worth $690K as of Q3 2026.
  • Sprott bought 869 Johnson & Johnson shares in Q3 2026, an estimated $229K.
  • Johnson & Johnson made up 0.02% of Sprott's portfolio in Q3 2026, its #164 holding.
  • Sprott first reported a position in Johnson & Johnson in Q2 2013 and has held it in 6 quarters since.
  • Sprott's Johnson & Johnson position peaked at $12.5M in Q1 2014.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.